NXGL NEXGEL, Inc.
Healthcare$0.54+0.93%ClosedMarket Cap: $4.9M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.11
P/S
0.44
EV/EBITDA
-3.07
DCF Value
$-266.03
FCF Yield
-28.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
38.9%
Operating Margin
-31.4%
Net Margin
-28.5%
ROE
-70.2%
ROA
-27.7%
ROIC
-40.8%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $2.6M | $-927.0K | $— |
| Q4 null | $2.8M | $-970.0K | $— |
| FY null | $11.4M | $-3.0M | $— |
| Q3 null | $2.9M | $-653.0K | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell
Maxim GroupBuy
2026-03-12Trading Activity
Insider Trades
View AllLevy Adam R.director, officer: Chief Executive Officer
BuyMon May 18
Levy Adam R.director, officer: Chief Executive Officer
BuyMon May 18
Kieser Brian Josephdirector
BuyMon May 18
Kieser Brian Josephdirector
BuyMon May 18
Kieser Brian Josephdirector
SellMon May 18
Company Info
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
—
Beta
0.74
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.